RDHL

RedHill Biopharma Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

$311.18 sample

+0.77 (+0.25%) 1D

Market cap

$1.63T

Price as of

2026-10-15

Latest filing

8-K · 2026-10-12

Alerts

8

Price$311.18 +14.05% 3M daily closessample

311.18266.10

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12SEC8-K filed: material event
Oct 06SEC8-K filed: material event
Sep 30INSInsider sell: EVP, Operations
Sep 24INSInsider sell: EVP, Operations
Sep 16INSInsider sell: Chief Executive Officer
Sep 09INSInsider sell: Chief Financial Officer
Sep 02INSInsider sell: 10% owner
Aug 25INSInsider sell: Chief Financial Officer

Sign up to see the real RDHL record →

Company facts

SEC EDGAR registration

Name: RedHill Biopharma Ltd.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: -59sample, -100 to +100
Reporting currency: USD

Who is positioning in RDHL

sample

Insiders: 9 insider transactions over 90 days, net selling, $772.8M
Congress: No member trades over 90 days
Institutions · 13F: 24 funds hold $34.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$55.6B +12.6% y/y

Q4 2024Q3 2026

Inventory$33.7B +12.2% y/y

Q4 2024Q3 2026

Accounts receivable$24.9B +12.1% y/y

Q4 2024Q3 2026

Total debt$70.6B +14.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $237.2B -2.9% 3M
Sample peer B: $1.47T -5.0% 3M
Sample peer C: $887.7B +5.5% 3M
Sample peer D: $1.53T +10.0% 3M
Sample peer E: $1.26T +4.6% 3M